健康元

Group Introduction
[Its Dual-Listed Companies] Joincare Pharmaceutical Group (Stock Code: 600380) Livzon Pharmaceutical Group (Stock Code: 000513 Hong Kong Stock Code: 01513)
img
Your location:
Homepage
/
/
/
Zhuhai Livzon Reagent Co., Ltd.

Zhuhai Livzon Reagent Co., Ltd.

  • Time of issue:2020-04-16 19:25
Views:

(Summary description) Zhuhai Livzon Reagent Co., Ltd. (hereinafter referred to as "Livzon Reagent") was founded in 1989 and is the first high-tech subsidiary of the listed company Livzon Pharmaceutical Group (A-share/H-share listed company), specializing in in vitro diagnostics The research and development, production and marketing of reagents and supporting equipment are one of the earliest in vitro diagnostic reagent manufacturers in China and a national high-tech enterprise. Livzon Reagent has successively established many technical platforms such as "enzyme-linked immunoassay, colloidal gold, microbes, molecular detection, multiple immunity, single chemiluminescence, fully automatic POCT, mast cell degranulation", etc., with strong multi-platform research and development capabilities and Fully automatic supporting equipment development technology. Products cover many fields such as "infectious diseases, respiratory tract infections, tumor marker detection, drug concentration monitoring, autoimmunity, allergen testing, and blood safety", and have a market share in the fields of respiratory tract infections, infectious diseases, drug concentration monitoring, etc. The market share of many products is as high as 50%-90%. The company has an industrialized base integrating R&D, production and office, covering an area of ​​more than 23,000 square meters, with a building area of ​​more than 44,000 square meters, of which the R&D area is 6000 square meters, which brings together many fields including laboratory medicine, biological engineering, etc. There are five R&D teams and three R&D centers in Zhuhai, Shanghai and Suzhou. R&D personnel account for nearly 20% of the professional talents, and the annual R&D investment exceeds 10% of sales revenue. At the same time of independent research and development, Livzon Reagent has established long-term good cooperation with world-class biomedical companies such as Fujirebro of Japan, Siemens of Germany, and MP of the United States, further enhancing the company's comprehensive service capabilities. The company has successively won the "National High-tech Enterprise", "Guangdong IVD Engineering Technology Research Center", "Guangdong Provincial Enterprise Technology Center", "Guangdong Province Innovative Enterprise" and the National "Postdoctoral Research Workstation", and has a complete The production quality management system has passed the national GMP certification, GSP certification and ISO13485/ISO9001 certification.

Zhuhai Livzon Reagent Co., Ltd.

(Summary description)
Zhuhai Livzon Reagent Co., Ltd. (hereinafter referred to as "Livzon Reagent") was founded in 1989 and is the first high-tech subsidiary of the listed company Livzon Pharmaceutical Group (A-share/H-share listed company), specializing in in vitro diagnostics The research and development, production and marketing of reagents and supporting equipment are one of the earliest in vitro diagnostic reagent manufacturers in China and a national high-tech enterprise.



Livzon Reagent has successively established many technical platforms such as "enzyme-linked immunoassay, colloidal gold, microbes, molecular detection, multiple immunity, single chemiluminescence, fully automatic POCT, mast cell degranulation", etc., with strong multi-platform research and development capabilities and Fully automatic supporting equipment development technology. Products cover many fields such as "infectious diseases, respiratory tract infections, tumor marker detection, drug concentration monitoring, autoimmunity, allergen testing, and blood safety", and have a market share in the fields of respiratory tract infections, infectious diseases, drug concentration monitoring, etc. The market share of many products is as high as 50%-90%.



The company has an industrialized base integrating R&D, production and office, covering an area of ​​more than 23,000 square meters, with a building area of ​​more than 44,000 square meters, of which the R&D area is 6000 square meters, which brings together many fields including laboratory medicine, biological engineering, etc. There are five R&D teams and three R&D centers in Zhuhai, Shanghai and Suzhou. R&D personnel account for nearly 20% of the professional talents, and the annual R&D investment exceeds 10% of sales revenue. At the same time of independent research and development, Livzon Reagent has established long-term good cooperation with world-class biomedical companies such as Fujirebro of Japan, Siemens of Germany, and MP of the United States, further enhancing the company's comprehensive service capabilities. The company has successively won the "National High-tech Enterprise", "Guangdong IVD Engineering Technology Research Center", "Guangdong Provincial Enterprise Technology Center", "Guangdong Province Innovative Enterprise" and the National "Postdoctoral Research Workstation", and has a complete The production quality management system has passed the national GMP certification, GSP certification and ISO13485/ISO9001 certification.

  • Time of issue:2020-04-16 19:25
  • Views:
Information

Zhuhai Livzon Reagent Co., Ltd. (hereinafter referred to as "Livzon Reagent") was founded in 1989 and is the first high-tech subsidiary of the listed company Livzon Pharmaceutical Group (A-share/H-share listed company), specializing in in vitro diagnostics The research and development, production and marketing of reagents and supporting equipment are one of the earliest in vitro diagnostic reagent manufacturers in China and a national high-tech enterprise.


Livzon Reagent has successively established many technical platforms such as "enzyme-linked immunoassay, colloidal gold, microbes, molecular detection, multiple immunity, single chemiluminescence, fully automatic POCT, mast cell degranulation", etc., with strong multi-platform research and development capabilities and Fully automatic supporting equipment development technology. Products cover many fields such as "infectious diseases, respiratory tract infections, tumor marker detection, drug concentration monitoring, autoimmunity, allergen testing, and blood safety", and have a market share in the fields of respiratory tract infections, infectious diseases, drug concentration monitoring, etc. The market share of many products is as high as 50%-90%.


The company has an industrialized base integrating R&D, production and office, covering an area of ​​more than 23,000 square meters, with a building area of ​​more than 44,000 square meters, of which the R&D area is 6000 square meters, which brings together many fields including laboratory medicine, biological engineering, etc. There are five R&D teams and three R&D centers in Zhuhai, Shanghai and Suzhou. R&D personnel account for nearly 20% of the professional talents, and the annual R&D investment exceeds 10% of sales revenue. At the same time of independent research and development, Livzon Reagent has established long-term good cooperation with world-class biomedical companies such as Fujirebro of Japan, Siemens of Germany, and MP of the United States, further enhancing the company's comprehensive service capabilities. The company has successively won the "National High-tech Enterprise", "Guangdong IVD Engineering Technology Research Center", "Guangdong Provincial Enterprise Technology Center", "Guangdong Province Innovative Enterprise" and the National "Postdoctoral Research Workstation", and has a complete The production quality management system has passed the national GMP certification, GSP certification and ISO13485/ISO9001 certification.

Scan the QR code to read on your phone

Quick Navigation

Service Hotline

Service

Hotline

Copyright © Joincare Pharmaceutical Group Industry Co., Ltd. All Rights Reserved.  Powered by:www.300.cn Zhuhai  粤ICP备14024104号